In the context of IUGR, abnormal lipid deposition in the liver may result from increased lipid transport and de novo synthesis, driven by upregulated expression of SREBP1c, stearoyl-CoA desaturase 1 (SCD1), and fatty acid binding protein 1 (FABP1) genes. The gene discussed is FABP1; the disease is fetal growth restriction.